文献速递腹部技术与安全CTMRPET

胰腺导管腺癌治疗反应评估:腹部放射学会关于形态学与功能成像技术作用的综述

Therapeutic response assessment in pancreatic ductal adenocarcinoma: society of abdominal radiology review paper on the role of morphological and functional imaging techniques.
PubMed 文献 · Abdom Radiol (NY) · 2020-09-16

胰腺导管腺癌多数患者以全身联合化疗为一线治疗,新辅助或姑息场景均如此,准确及时评估治疗反应对指导治疗、减少无效治疗毒性及成本、辅助适应性临床试验至关重要。传统形态学成像在判断原发肿瘤反应和新辅助治疗后可切除性方面有显著局限。本文概述当前治疗选择,强调有助于减少新辅助治疗后过度分期的形态学表现,并讨论在更精确量化疾病负荷和治疗反应方面显示前景的新兴成像与非成像工具。

要点

  • 传统形态学成像判断胰腺导管腺癌原发肿瘤反应和新辅助治疗后可切除性有显著局限。
  • 部分形态学表现可能有助于减少新辅助治疗后的过度分期。
  • 新兴成像与非成像工具在更精确量化疾病负荷和治疗反应方面显示前景。

核心结论

  • 传统形态学成像在确定原发肿瘤反应和新辅助治疗后可切除性方面有显著局限。
  • 部分形态学表现可能有助于减少新辅助治疗后的过度分期。
  • 多种新兴成像与非成像工具在更精确量化胰腺导管腺癌疾病负荷和治疗反应方面显示前景。

研究设计与样本

  • 本文为腹部放射学会综述,概述胰腺导管腺癌当前治疗选择、形态学成像表现及新兴成像与非成像工具。

关键影像表现/征象

  • 部分形态学成像表现可能有助于减少新辅助治疗后的过度分期。

临床应用与阅片要点

  • 对胰腺导管腺癌患者,准确及时评估治疗反应对指导治疗、减少无效治疗的毒性和成本、辅助适应性临床试验至关重要。
  • 传统形态学成像判断原发肿瘤反应和新辅助治疗后可切除性有显著局限,阅片时需注意。

局限性

  • 传统形态学成像在确定原发肿瘤反应和新辅助治疗后可切除性方面有显著局限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Pancreatic ductal adenocarcinoma (PDA) is the third leading cause of cancer-related death in the United States and is projected to be the second by 2030. Systemic combination chemotherapy is considered an essential first-line treatment for the majority of patients with PDA, in both the neoadjuvant and palliative settings. In addition, a number of novel therapies are being tested in clinical trials for patients with advanced PDA. In all cases, accurate and timely assessment of treatment response is critical to guide therapy, reduce drug toxicities and cost from a failing therapy, and aid adaptive clinical trials. Conventional morphological imaging has significant limitations, especially in the context of determining primary tumor response and resectability following neoadjuvant therapies. In this article, we provide an overview of current therapy options for PDA, highlight several morphological imaging findings that may be helpful to reduce over-staging following neoadjuvant therapy, and discuss a number of emerging imaging, and non-imaging, tools that have shown promise in providing a more precise quantification of disease burden and treatment response in PDA.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Wang ZJ, Arif-Tiwari H, Zaheer A, et al. Therapeutic response assessment in pancreatic ductal adenocarcinoma: society of abdominal radiology review paper on the role of morphological and functional imaging techniques. Abdom Radiol (NY). 2020. PMID: 32936417. doi:10.1007/s00261-020-02723-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。